Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
| ▸ | STS | P08842 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7271811 | 1.00 | EPHX1 (0.42) | EPHX1NAAAHTTCYP2C19OPRK1 | |
| SCHEMBL1322130 | 0.98 | EPHX1 (0.39) | EPHX1NAAAHTTCYP2C19OPRK1 | |
| SCHEMBL1322127 | 0.98 | EPHX1 (0.39) | EPHX1NAAAHTTCYP2C19OPRK1 | |
| SCHEMBL1319123 | 0.94 | EPHX1 (0.35) | EPHX1NAAAHTTCYP2C19OPRK1 | |
| SCHEMBL1319121 | 0.94 | EPHX1 (0.35) | EPHX1NAAAHTTCYP2C19OPRK1 | |
| SCHEMBL11050292 | 0.90 | ATM (0.31) | — | |
| SCHEMBL11562387 | 0.82 | EPHX1 (0.39) | EPHX1NAAAHTTCYP2C19CA12 | |
| SCHEMBL7427693 | 0.81 | OPRK1 (0.38) | OPRK1 | |
| SCHEMBL7427690 | 0.81 | OPRK1 (0.38) | OPRK1 | |
| SCHEMBL20530252 | 0.81 | EPHX1 (0.42) | EPHX1NAAAHTTCYP2C19CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5276150-A | Vasodilators, anticoagulants, calcium channel blockers | FUJIREBIO INC. (JP) | 1994-01-04 | — | — | US | disclosed |
| EP-0461264-A1 | ETHYNYLPHENYL DERIVATIVE, PRODUCTION THEREOF, AND REMEDY FOR DISEASES OF CIRCULATORY ORGANS CONTAINING THE SAME AS ACTIVE INGREDIENT | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| EP-0400660-A1 | 1,4-dihydropyridine derivatives | FUJIREBIO INC. (JP) | 1990-12-05 | — | — | EP | disclosed |
| US-4558058-A | HYPOTENSIVE AGENTS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1985-12-10 | — | — | US | disclosed |